DNASE1 and COVID-19: Against the background of targeted therapy, in January 2022, the girl fell ill with COVID-19: fever up to 39.3 °C for 3 days, headaches, weight loss (PCR test dated 17 January 2022—positive); against this background, her dose of dornase alfa was doubled and she took antipyretics as needed.